As of August 28, 2026, Amneal Pharmaceuticals, Inc. (AMRX) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Amneal Pharmaceuticals, Inc. has a market capitalization of $4.20B, 319.35M shares outstanding, 319 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AMRX.
Market Data
Market Cap$4.20B
Shares Outstanding319.35M
Float178.41M
Cash$127.64M
Debt$2.57B
Short InterestN/A
Institutional Holdings
QoQ: ↑ 13.2% shares (2026Q1 vs prior)
319 institutional holders · 182.27M shares
#1
BlackRock, Inc.
24.52M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
15.17M shares
#3
MORGAN STANLEY
12.96M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest8.32M
Days to Cover4.6
% of Float4.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2019-12-31
Form 4
INSIDER TRANSACTION
2026-08-10
4
INSIDER TRANSACTION
2026-03-05
4
INSIDER TRANSACTION
2026-03-05
4
INSIDER TRANSACTION
2026-03-05
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual AMRX Dilution Snapshot
Amneal Pharmaceuticals, Inc. (AMRX) has a DilutionScore of 14/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for AMRX: Form 4 on 2026-08-10; 4 on 2026-03-05; 4 on 2026-03-05.
- Score coverage note: Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track AMRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AMRX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Cash Runway is marked not applicable or unavailable while debt exceeds cash in stored market data; do not read the overall score as a complete balance-sheet risk assessment.
More Research for AMRX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.